key: cord-0691933-t7otgzlu
authors: Khan, Haroon; Alam, Waqas; Alsharif, Khalaf F.; Aschner, Michael; Pervez, Samreen; Saso, Luciano
title: Alkaloids and Colon Cancer: Molecular Mechanisms and Therapeutic Implications for Cell Cycle Arrest
date: 2022-01-28
journal: Molecules
DOI: 10.3390/molecules27030920
sha: af72cfcad1e76921c2b425c563508218d6f15fad
doc_id: 691933
cord_uid: t7otgzlu

Cancer is the second most fatal disease worldwide, with colon cancer being the third most prevalent and fatal form of cancer in several Western countries. The risk of acquisition of resistance to chemotherapy remains a significant hurdle in the management of various types of cancer, especially colon cancer. Therefore, it is essential to develop alternative treatment modalities. Naturally occurring alkaloids have been shown to regulate various mechanistic pathways linked to cell proliferation, cell cycle, and metastasis. This review aims to shed light on the potential of alkaloids as anti-colon-cancer chemotherapy agents that can modulate or arrest the cell cycle. Preclinical investigated alkaloids have shown anti-colon cancer activities and inhibition of cancer cell proliferation via cell cycle arrest at different stages, suggesting that alkaloids may have the potential to act as anticancer molecules.

Cancer is the second most fatal disease in the world, and according to the World Health Organization (WHO), it accounted for approximately 8.2 million deaths and 14 million new victims in 2012 [1] . In 2017, the projected deaths due to different cancers in the United States were 600,920, with 1,688,780 newly diagnosed cancer patients. The overall cancer prevalence and death rate was 20% higher in males than in females [2] . The coronavirus disease 2019 (COVID-19) pandemic impeded cancer detection and therapy in 2020. In 2021, the United States was projected to have 1,898,160 cancer cases and 608,570 cancer-related deaths [3] . Older people, between 85-90 years-of-age, have higher cancer prevalence than younger subjects [4] . The rapid and unmanageable proliferation of abnormal cells leads to cancer origination [5] , with abnormalities during cellular division in the mitochondrial genome triggering genetic mutations and cancer progression [4] .

Colon cancer (CC) is one of the most prevalent cancers in the world, with the highest prevalence in Black Alaska's Natives and the lowest prevalence in Asian/Pacific Islanders [6] . Colorectal cancer (CRC) is the most prevalent cancer in Saudi men, and the third most prevalent disease in Saudi women [7] . The American Cancer Society has drafted guidelines for the treatment of colon cancer as well as survivorship care, which include long-term complications from chemotherapy [8] [9] [10] .

While diagnostic and treatment options for colon cancer have been stipulated [11] [12] [13] , their outcomes are not always satisfactory, and the number of deaths remains high. Colon transcription in the G1 phase is strongly associated with the transcription factors of E2F coupled with their dimerization partner proteins. Researchers have found functional regulation factors of E2F in cancer [63, 64] , suggesting that G1-S transcription is critical in the development and proliferation of cancer [65] [66] [67] .

The S phase is followed by the Gap 2 (G2) phase, characterized by a synthesis/repair phase coupled with the preparation of cellular machinery for mitosis in the M (mitosis) phase [68, 69] . The chromatids and daughter cells separate during the M phase. Subsequently, the cells enter theG1 or G0. The quality and rate of overall cell division is modulated by these checkpoints [70, 71] . In this phase, the cdc2-B1 complex is regulated via the activation of phosphate by the Cdk-activating enzyme and the inhibition of phosphatase enzymes [72] . The phosphatase Cdc25C caused dephosphorylation and hence overexpression of Cdk [73] [74] [75] .

The dormant cells are activated by external stimuli [76] . These growth-promoting factors bind to cell receptors and trigger the cellular machinery [77] . Moreover, genetic intervention has been observed as the focusing target of these growth-modulating factors [78] . The response is designated as earlier and delayed. The former induces phosphorylation and activation of the transcription factor proteins that are already present in the cell. In fact, the genes that are involved in early response encode transcription factors, and ultimately modulate the expression of late response genes. The delayed response genes modulate the proteins, G1 cyclin-dependent kinases (CDKs) [79, 80] , and therefore CDK inhibitors have recently attracted considerable attention as anticancer agents, especially the CDK4 and CDK6 inhibitors [81, 82] .

In 2001, Ogasawara et al. reported on the anticancer activity of evodiamine 1 (Table 1) Koduru and co-researchers (2007) isolated steroidal alkaloids, named as tomatidine 6 and solasodine 7, from Solanum aculeastrum (Figure 1 ) [83] . Sanguinarine 8, a benzophenanthridine alkaloid isolated from the roots of Sanguinaria canadensis, evoked a significant anticancer effect [84] . Subsequently, in 2012, Lee et al. reported other work about the antiproliferative activity of this alkaloid [85] .

Schematic representation of molecular mechanisms of action involved in anticancer effect of steroidal alkaloids in colonic cancer. Steroidal alkaloids inhibit different pathways such aspg-p, PI3k, Fas, and TNRfs, which are, in turn, linked with different mechanistic pathways exhibiting anticancer effects. Inhibition of Bax and Bcl2 leads to activation of caspase-3,8, and 9 pathways, thus leading to apoptosis.

The summary of the activity of synthetic alkaloid derivatives with potential therapeutic effect in colon cancer is shown in Table 2 . The derivative exatecan mesylate ((1S,9S)-1-amino-9-ethyl-5-fluoro-2,3-dihydro-9-hydroxy-4-methyl-1H,12H-benzo(de) pyrano(3′,4′-6,7)indolizino(1,2-b)quinoline-10,13(9H,15H)dionemethanesulfonate)64 from camptothecin, a quinoline indole alkaloid with antiproliferative activity, was investigated by Hattum et al. (2002) for anticancer activity against several colon cancer cell lines (COLO205-IC50: 0.61 ng/mL, COLO320-IC50: 0.52 ng/mL, LS174T-IC50: 2.8 ng/mL, SW-1398-IC50: 2.7 ng/mL, and WiDr-IC50: 7.5 ng/mL, for in vitro activity). The activity was also observed in an in vivo model, and this derivative was considered more potent than topotecan and SN-38 [104] . 

Piper nigrum

Tabernaemontana corymbosa [96] Piper nigrum [97, 98] Tabernaemontana elegans vobasinyl−iboga Alkaloids

[99] [97, 98] Tabernaemontana elegansvobasinyl−ibogaAlkaloids Tabernaemontana corymbosa [96] Piper nigrum [97, 98] Tabernaemontana elegans vobasinyl−iboga Alkaloids Korean researchers isolated several alkaloids 9-22 from Corydalis ternate phytochemicallyy [90] . These were characterized as epi-coryximine 9, coryternatines A 10, (Table 1) , a bisbenzylisoquinoline alkaloid, inhibited four lines of colon cancer cells (HCT-116, HCT-8, SW620, and SW480). The mechanism involved the inhibition of proliferation/invasion and induction of apop-63 (IC 50 = 5.32 µM) [103] Korean researchers isolated several alkaloids 9-22 from Corydalis ternate phytochemicallyy [90] . These were characterized as epi-coryximine 9, coryternatines A 10, coryternatines B 11, coryternatines C 12, coryternatines D 13, (S)-reticuline, (R)-reticuline 14, [102] , with IC 50 values of 5.7 mM and 17.9 mM, respectively. An alkaloid isolated from Goniothalamus lanceolatus, namely, goniolanceolactam 63, showed potent cytotoxicity against the colon cell line with IC 50 value of 5.32 µM [103] . A schematic representation of molecular pathways of the anticancer effect of steroidal alkaloids in colon cancer is presented in Figure 1 .

The summary of the activity of synthetic alkaloid derivatives with potential therapeutic effect in colon cancer is shown in Table 2 In 2007, Italian researchers synthesized nortopsentin analogues of marine alkaloids, such as 3,5-bis(3′-indolyl)pyrazol 65 and 1-chloro-3,5-bis(3′-indolyl)pyrazol 66, earlierisolated from Spongosorites (Table 2) . The analogue 1-chloro-3,5-bis(3′-indolyl) pyrazol, bearing a chloro group, was more active both in terms of GI50 and of percentage of sensitive cell lines. Plakinamines N and O, two additional steroidal alkaloids from Corticium niger, as well as two established plakinamine compounds, were isolated (3, 4) . Using a combination of MS and NMR spectroscopic data, the structures of these molecules were characterized. The antineoplastic effectiveness of plakinamines N, O, and J was examined in the NCI-60 screen, and they demonstrated improved inhibitory activity against all colorectal cell cultures [105] . Table 2 . Synthetic alkaloid derivatives with potential in colon cancer.

Derivatives Reference [108] .

These stereoselective amid alkaloids exhibited a marked anticancer effect against HT-29 colon cell lines with 125 and 181µg/mL, respectively. Similarly, several [113] Luo et al. [108] .

These stereoselective amid alkaloids exhibited a marked anticancer effect against HT-29 colon cell lines with 125 and 181µg/mL, respectively. Similarly, several 5-Phenyl-4,5dihydro-1,3,4-thiadiazole derivatives were synthesized by Alam and colleagues. These include N-(4-Acetyl-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)acetamide 70, N-(4-Acetyl-5-p-tolyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)acetamide 71, N-(4-Acetyl-5-(4-nitrophenyl)-4,5dihydro-1,3,4-thiadiazol-2-yl)-acetamide 72, N-(4-Acetyl-5-(3-nitrophenyl)-4,5-dihydro-1,3,4thiadiazol-2-yl)-acetamide 73, N-(4-Acetyl-5-(3-(dimethylamino)phenyl)-4,5-dihydro-1,3,4thiadiazol-2-yl)acetamide 74, N-(4-Acetyl-5-(4-chlorophenyl)-4,5-dihydro-1,3,4-thiadiazol-2yl)-acetamide 75, N-(4-Acetyl-5-(4-bromophenyl)-4,5-dihydro-1,3,4-thiadiazol-2-yl)-acetamide 76, N-(4-Acetyl-5-(4-hydroxyphenyl)-4,5-dihydro-1,3,4-thiadiazol-2-yl)-acetamide 77, N-(4-Acetyl-5-(4-methoxyphenyl)-4,5-dihydro-1,3,4-thiadiazol-2-yl)-acetamide 78, and N-(4-Acetyl-5-(4-hydroxy-3-methoxyphenyl)-4,5-dihydro-1,3,4-thiadiazol-2-yl)acetamide 79 [109] .

Berberine 80 is a highly studied isoquinoline plant alkaloid isolated from many species of the genus berberis [114] . Italian researchers synthesized a number of berberine 80 derivatives, which were characterized as [13-(3- which increased to about 50% with the recovery time, whereas NAX018 demonstrated a cytotoxic effect after the treatment in about 50%, reaching 70% after the recovery time. InSW-613-B3 cells, the incubation with 10 µM NAX012 and NAX014 was not effective, while NAX018 affected cell survived by 10% and 20% (at the completion of incubation and after the recovery response, respectively).In particular, when compared to the lead compound BBR, these derivatives showed high potency, being more effective in cells harboring p53wt, promoting cell cycle arrest and DNA damage, and triggering caspase-dependent apoptosis and autophagy [111] . Ilyas and his coauthors established the anticancer efficacy of doxorubicin (of synthetic origin) combined with berberine (of natural origin)by applying an encapsulation/conjugation approach with poly (lactic-co-glycolic acid) PLGA nanoparticles. By using carbodiimide chemistry, doxorubicin has been effectively conjugated to PLGA, and the PLGA-doxorubicin conjugate (PDC) was employed to encapsulate berberine. ROS analysis demonstrated that the PDBNP depicted a dose-dependent rise in the reactive oxygen species (ROS) patterns in MDA-MB-231 cells, but no improvement in ROS was detected in T47D cells. PDBNP caused a change (depolarization) in mitochondrial membrane permeability as well as a cell cycle arrest in the sub-G1 phase, whilst Annexin V/PI assay, followed by confocal microscopy, revealed that MDA-MB-231 cells died due to necrosis.

Paternaet al. (2015) synthesized derivatives from monoterpene-indole alkaloid hydrazone and evaluated their activity against HCT-116 colon cancer. The derivatives containing the 5-bromo-pyridine (dregamine 5-bromo-pyridin-2-ylhydrazone 89 and tabernaemontanine 5-bromo-pyridin-2-ylhydrazone 90) ring were the most cytotoxic, reducing cell viability by over 95% at 25 µM. The derivative tabernaemontanine phenylhydrazone 91 reduced cell viability to the same level at 50 µM.

Similarly, a Chinese research group synthesized phenanthroindolizidine, which was characterized as 2-(((3,6,7-trimethoxyphenanthren-9-yl)methyl)amino)ethanol 92 and 2-(((2,3,6,7-tetramethoxyphenanthren-9-yl)methyl)amino)ethanol 93. These compounds exhibited potent effects against the colon cancer cell line HT-29 [113] .

The anticancer effect of alkaloids and the mechanistic pathways involved in the anticancer effect of alkaloids are schematically represented in Figure 2 . Piperine 51, an alkaloid commonly isolated from black pepper [98] , mediated its anticancer effect via modulation of G1-phase cell cycle arrest and by downstream regulation of cyclins D1 and D3, accompanied by their activating cofactors, cyclin-dependent kinases 4 and 6. Piperine caused downstream expression of phosphorylation of retinoblastoma protein and upstream modulation of p21/WAF1 and p27/KIP1 expression ( Figure 2 ) [97] . The G1 expression for the initiation of Rb protein phosphorylation shape D-type cyclin complexes with Cdk4 and Cdk6 [115, 116] .On the other hand, to expresses cell cycle progression, it caused inhibition of cyclin-dependent kinases when this complex attached to p21/WAF1 and p27/KIP1, an inhibitor of cyclin-dependent kinases [117, 118] . Isoquinoline alkaloids also inhibit Cyclin D CDK 4/6 and causes cell cycle arrest. mTOR pathway is also activated, which leads to autophagy.

The African medicinal plant Tabernaemontana elegans yielded obasinyl-iboga alkaloids dregamine52, and tabernaemontanine53 exhibited significant antiproliferative activity by modulating its effect through G1-phase arrest in colon cancer cell lines with associated downstream regulation in the S phase [99] . Arun et al. (2017) studied the effect of pyranocarbazole alkaloids, murrayazoline compound 61, and O-methylmurrayamine A compound62 in different stages of the cell cycle; both caused significant cell arrest at the G2/M checkpoint and promoted sub-diploid population at 5.7 µM and 17.9 µM, respectively [102] .

The synthetic phenanthroindolizidine alkaloids (92 and 93) showed strong anticancer action by modulating multiple singling pathways. These compounds at a low concentration (5 µg/mL) elicited cell cycle arrest, while targeting the G2/M phase. The synthetic phenanthroindolizidine alkaloids (92 and 93) showed strong anticancer action by modulating multiple singling pathways. These compounds at a low concentration (5 µg/mL) elicited cell cycle arrest, while targeting the G2/M phase. Moreover, a noticeable reduction in cell distribution was observed at the G0/G1 and S phases. In addition, Min et al. (2012) described the effects of another phenanthroindolizidine alkaloid, antofine 41, in HCT-116 cells, causing cell cycle arrest at the G0/G1 phases and inhibiting the expression of cyclin D1, cyclin E, CDK4, and the transcriptional activity of β-catenin/Tcf. Moreover, this alkaloid also potentiated tumor necrosis factor-a (TNF-α)-induced apoptosis and reduced the expression level of β-catenin and cyclin D1 in SW-480 cells [119] .

Mechanistic studies on compounds 6 and 7 showed inhibition of the G0/G1 phase after 24 h exposure [83] , with directed cell death absent mitochondrial alterations [120] . The antiproliferative effects of alkaloids 42-44 (Table 1) from Zanthoxylum capense in HCT-116 cell were shown to be mediated by apoptosis (Figure 1 ) [94] . Yang et al. (2010) showed that the arrest of the G1 phase in colon cancer cells and the induction of apoptosis are associated with the suppression of nuclear factor-kappaB (NF-kB) activation. The alkaloid also inhibited the phosphorylation/degradation of IkBa and the phosphorylation/translocation of p65. Furthermore, dauricine down-regulated the expression of various NF-kB-regulated genes, including genes involved in cell proliferation (COX-2, cyclin D1, and c-Myc), invasion (MMP-9 and ICAM-1), antiapoptosis (Bcl-2, XIAP, IAP1, and survivin), and angiogenesis (VEGF). The diversity of anticancer mechanisms was also noted with isostrychnopentamine (ISP) 2, an indolomonoterpenic alkaloid that causes cell cycle arrest in the G2-M phase, and induces apoptosis by the translocation of phosphatidylserine from the inner layer to the outer layer of the plasma membrane, as well as by chromatin condensation, DNA fragmentation, and activation of the caspases 3 and 9 [91] .

An experimental finding has illustrated a strong cytotoxic effect of oxymatrine 63, an alkaloid isolated from Sophora flavescens in human colon cancer cells. The underlying mechanism was interfering with the overexpression of human telomerase reverse transcriptase and causing up-regulation of hTERT, c-myc, p53, and mad1 [121] . The overall effect was concentration dependent (Figure 1 ) [122] .

Cancer chemotherapy is limited by cellular drug resistance [123] [124] [125] [126] . In this regard, different mechanisms have been implied for this resistance, including cell cycle arrest and repair [127] , apoptosis [128] , cancer stem cells [129] , drug properties/nature [130] , and metabolism of the drug [131] . Cell cycle arrest plays a crucial role in drug resistance to chemotherapy in various cancers [127] . Several studies have confirmed the involvement of checkpoint kinase (CHK1) in chemoresistance and even resistance in radiotherapy [132] [133] [134] . In the case of DNA damage, the complex cellular signaling network becomes activated and induces cell cycle arrest, thus facilitating DNA-repairing events or, in cases of extensive damage, such events trigger apoptosis [135] [136] [137] .

Damage of the cellular DNA of any origin triggers the activation/upstream regulation of ATM(ataxia-telangiectasia mutated),and ATR(ATM-and Rad3-related) kinases coupled with the DNA-dependent protein kinase catalytic subunit [135, 138] . These kinases lead to the translocation of components to the sites of damaged DNA and induce cell cycle progression by modulating effector kinases and checkpoint kinase like CHK1, and CHK2 [139] . The activation of checkpoints controlled by ATM/ATR-CHK1/CHK2 stalls cell cycle progression in the G1, S, or G2 phase [140] . G1 arrest is modulated by p53 through p21CIP1/WAF1 up-regulation [141] , while in case of DNA damage, apoptosis charged over the situation [130] . In the course of events, p53 loses its regulatory action; as a result, the chemotherapy-induced DNA damage is unable to arrest the cancer cells in the G1 phase and thus trigger apoptosis. Indeed, to arrest the cell cycle in such cancer cells, following the genotoxic exposure, the S and G2/M checkpoints are required to induce DNA repair before entry into mitosis (M phase). Different polysulfanes have shown cell cycle arrest in colorectal cancer [142] [143] [144] .

Based on increased cases of cancer and its status as a leading cause of disease worldwide, new effective treatments are required. Among the most common cancer treatments, chemotherapy is an essential tool in getting cancer under control and reducing or treating advanced or aggressive cancers. As noted in the current review, several alkaloids show anti-colon-cancer properties, being able to be cytotoxic against human colon cancer cells. The most exciting substances seem to be those able to act at the level of the checkpoints present at the G1/S and G2/M transitions, which account for the proper replication and division of DNA. These alkaloids hold great potential as novel therapeutic agents for the effective management of colon cancer. 

Emerging cytotoxic alkaloids in the battle against cancer: Overview of molecular mechanisms

Cancer statistics

Cancer statistics, 2021

Cancer-Incidence, prevalence and mortality in the oldest-old. A comprehensive review

Cancer-promoting mechanisms of tumor-associated neutrophils

Colorectal cancer statistics

Colorectal cancer in Saudi Arabia as the proof-of-principle model for implementing strategies of predictive, preventive, and personalized medicine in healthcare

Pharmacological and toxicological profile of harmane-β-Carboline alkaloid: Friend or foe

of Clinical Oncology clinical practice guideline update

Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: An American Society of Clinical Oncology guideline adaptation

Proteins are potent biomarkers to detect colon cancer progression

Usefulness of preoperative CT colonography for colon cancer

Randomized clinical trials in colon and rectal cancer

Colorectal Cancer Survivorship Care Guidelines

Synthesis of novel anthraquinones: Molecular structure, molecular chemical reactivity descriptors and interactions with DNA as antibiotic and anti-cancer drugs

Anti-tumor effects of differentiation-inducing factor-1 in malignant melanoma: GSK-3-mediated inhibition of cell proliferation and GSK-3-independent suppression of cell migration and invasion

Nutrition and physical activity guidelines for cancer survivors

Further screening of the resin glycosides in the edible water spinach and characterisation on their mechanism of anticancer potential

Nanomedicines in the treatment of colon cancer: A focus on metallodrugs

Revival of natural products: Utilization of modern technologies

Medicinal plants in light of history recognized therapeutic modality

Brilliant future of phytomedicines in the light of latest technological developments

Plant-derived mPGES-1 inhibitors or suppressors: A new emerging trend in the search for small molecules to combat inflammation

Flavonoids as acetylcholinesterase inhibitors: Current therapeutic standing and future prospects

Antimicrobial and anti-oxidant potential of berberisinol, a new flavone from Berberis baluchistanica

Apigenin as neuroprotective agent: Of mice and men

Targeting BDNF modulation by plant glycosides as a novel therapeutic strategy in the treatment of depression

Alkaloids as drug leads-A predictive structural and biodiversity-based analysis

Natural alkaloids: Basic aspects, biological roles, and future perspectives

Therapeutic potential of songorine, a diterpenoid alkaloid of the genus Aconitum

Biology of alkaloids. In Alkaloids

Plant alkaloids as antiplatelet agent: Drugs of future in the light of recent development

Antioxidant potential of cyclopeptide alkaloids isolated from Zizyphus oxyphylla

Advances in antioxidant potential of natural alkaloids

Antinociceptive activity of cyclopeptide alkaloids isolated from Ziziphus oxyphylla Edgew (Rhamnaceae)

Anti-anaphylactic and anti-inflammatory activities of a bioactive alkaloid from the root bark of Plumeria acutifolia Poir

Alkaloids: Potential therapeuty modality in the management of asthma

Anti-cancer potential of phyto-alkaloids: A prospective review Curr

Alkaloids: An emerging antibacterial modality against Methicillin Resistant Staphylococcus aureus

ACE inhibition of plant alkaloids. Targeted approach for selective inhibition

Solamargine, a bioactive steroidal alkaloid isolated from Solanum aculeastrum induces non-selective cytotoxicity and P-glycoprotein inhibition

Screening of medicinal plants traditionally used in Peruvian Amazon for in vitro antioxidant and anticancer potential

Targeting apoptosis pathways in cancer and perspectives with natural compounds from mother nature

Alkaloids isolated from natural herbs as the anticancer agents. Evid. -Based Complementary Altern

The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer. Pediatric Blood Cancer

Management of complicated hemangiomas with vincristine/vinblastine: Quantitative response to therapy using MRI

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: The ICON4/AGO-OVAR-2.2 trial

Berberine: A novel therapeutic strategy for cancer

Cell cycle arrest as a therapeutic target of acute kidney injury

Ethanol-induced methylation of cell cycle genes in neural stem cells

The spindle assembly checkpoint in arabidopsis is rapidly shut off during severe stress

To arrest or not to G2-M cell-cycle arrest

The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance

Study on the mechanism of cell cycle checkpoint kinase 2 (CHEK2) gene dysfunction in chemotherapeutic drug resistance of triple negative breast cancer cells

Chk1 is haploinsufficient for multiple functions critical to tumor suppression

NEIL3 repairs telomere damage during S phase to secure chromosome segregation at mitosis. Cell Rep

Cell responses to DNA damage

Much more than a DNA damage responsive protein

BDE-47 and BDE-209 inhibit proliferation of Neuro-2a cells via inducing G1-phase arrest

Dux4 induces cell cycle arrest at G1 phase through upregulation of p21 expression

Chapter 10-Lysine Demethylases: Structure, Function, and Disfunction A2-Binda, Olivier

The RB/E2F pathway and regulation of RNA processing

Control of cell cycle transcription during G1 and S phases

E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells

E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1

Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiation

Chapter 14-Irreversible transitions, bistability and checkpoint controls in the eukaryotic cell cycle: A systems-level understanding A2-walhout

Tumor-suppressor genes, cell cycle regulatory checkpoints, and the skin

The spindle assembly checkpoint is required for hematopoietic progenitor cell engraftment

Critical role of cyclin B1/Cdc2 up-regulation in the induction of mitotic prometaphase arrest in human breast cancer cells treated with 2-methoxyestradiol

Ultrasensitivity in the Regulation of Cdc25C by Cdk1

The cell cycle: A review of regulation, deregulation and therapeutic targets in cancer

Cell cycle control as a basis for cancer drug development

Dormancy of solitary metastatic cells

Deconstructing stem cell self-renewal: Genetic insights into cell-cycle regulation

Flavonoids from Chinese bayberry leaves induced apoptosis and G1 cell cycle arrest via Erk pathway in ovarian cancer cells

Tebufenozide induces G1/S cell cycle arrest and apoptosis in human cells

Inhibitors of cyclin-dependent kinases as cancer therapeutics

Cyclin dependent kinase (CDK) inhibitors as anticancer drugs

Anticancer activity of steroid alkaloids isolated from Solanum aculeastrum

Hellmann-Blumberg, U. Sanguinarine causes DNA damage and p53-independent cell death in human colon cancer cell lines

Sanguinarine induces apoptosis of HT-29 human colon cancer cells via the regulation of Bax/Bcl-2 ratio and caspase-9-dependent pathway

Inhibitory effects of evodiamine on in vitro invasion and experimental lung metastasis of murine colon cancer cells

In vitro and in vivo antimalarial properties of isostrychnopentamine, an indolomonoterpenic alkaloid from Strychnos usambarensis

Montamine, a unique dimeric indole alkaloid, from the seeds of Centaurea montana (Asteraceae), and its in vitro cytotoxic activity against the CaCo2 colon cancer cells

Benzylisoquinoline alkaloids from the tubers of Corydalis ternata and their cytotoxicity

Synergistic actions of atorvastatin with γ-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells

New cytotoxic quinolone alkaloids from fruits of Evodia rutaecarpa

Neuroprotective compounds isolated from Cynanchum paniculatum

Apoptosis inducing activity of benzophenanthridine-type alkaloids and 2-arylbenzofuran neolignans in HCT116 colon carcinoma cells

Alkaloids from Acorus gramineus rhizomes and their biological activity

New vobasinyl-ibogan type bisindole alkaloids from Tabernaemontana corymbosa

an alkaloid from black pepper, inhibits growth of human colon cancer cells via G1 arrest and apoptosis triggered by endoplasmic reticulum stress

Extraction, identification, formulation and evaluation of piperine in alginate beads

Vobasinyl-Iboga Alkaloids from Tabernaemontana elegans: Cell Cycle Arrest and Apoptosis-Inducing Activity in HCT116 Colon Cancer Cells

Melodinine V, an antitumor bisindole alkaloid with selective cytotoxicity from Melodinus henryi

Cytotoxicity of alkaloids isolated from Argemone mexicana on SW480 human colon cancer cell line

Anti-colon cancer activity of Murraya koenigii leaves is due to constituent murrayazoline and O-methylmurrayamine A induced mTOR/AKT downregulation and mitochondrial apoptosis

Cytotoxic lactam and naphthoquinone alkaloids from roots of Goniothalamus lanceolatus Miq

The activity profile of the hexacyclic camptothecin derivative DX-8951f in experimental human colon cancer and ovarian cancer

Steroidal alkaloids from the marine sponge Corticium niger that inhibit growth of human colon carcinoma cells

Synthesis and antitumor properties of 2, 5-bis (3 -indolyl) thiophenes: Analogues of marine alkaloid nortopsentin

Anti-cancer effects of JKA97 are associated with its induction of cell apoptosis via a Bax-dependent and p53-independent pathway

First stereoselective total synthesis and anticancer activity of new amide alkaloids of roots of pepper

Cytotoxicity of new 5-phenyl-4,5-dihydro-1,3,4-thiadiazole analogues

Multiple effects of berberine derivatives on colon cancer cells

Effect of new berberine derivatives on colon cancer cells

Monoterpene indole alkaloid hydrazone derivatives with apoptosis inducing activity in human HCT116 colon and HepG2 liver carcinoma cells

In vitro anticancer effects of two novel phenanthroindolizidine alkaloid compounds on human colon and liver cancer cells

New perspectives for old remedies

Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6

Role of the RB-Interacting Proteins in Stem Cell Biology

Agastache rugosa Kuntze extract, containing the active component rosmarinic acid, prevents atherosclerosis through up-regulation of the cyclin-dependent kinase inhibitors p21WAF1/CIP1 and p27KIP1

Control of cyclin D1, p27Kip1, and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension

Nitric oxide (NO) and NO synthases (NOS)-based targeted therapy for colon cancer

Chemistry and anticarcinogenic mechanisms of glycoalkaloids produced by eggplants, potatoes, and tomatoes

Experimental study of the killing effects of oxymatrine on human colon cancer cell line SW1116

Understanding the effectiveness of natural compound mixtures in cancer through their molecular mode of action

Lysosomes as mediators of drug resistance in cancer Drug Resist

Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance. Drug Resist. Update

Toward a better understanding of the complexity of cancer drug resistance

Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics. Drug Resist. Updates

TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy. Drug Resist

Apoptosis and melanoma chemoresistance

Mechanisms of chemoresistance in cancer stem cells

Regulatory players of DNA damage repair mechanisms: Role in cancer chemoresistance

Mechanism of cell adaptation: When and how do cancer cells develop chemoresistance?

DNA repair and resistance of gliomas to chemotherapy and radiotherapy

DNA damage detection and repair pathways-Recent advances with inhibitors of checkpoint kinases in cancer therapy

Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis

5-FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53-mutated colon cancer cells

Regulation of p53

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage

ATM-and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks

Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy

p53 suppression of arsenite-induced mitotic catastrophe is mediated by p21CIP1/WAF1

Blinded by the light: The growing complexity of p53

Cellular senescence and cancer treatment

Chapter 1-Pathways linked to cancer chemoresistance and their targeting by nutraceuticals. In Role of Nutraceuticals in Cancer Chemosensitization